Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.05 USD | -1.06% | -2.66% | -8.09% |
Financials (USD)
Sales 2024 * | 10M | Sales 2025 * | 6.25M | Capitalization | 1.23B |
---|---|---|---|---|---|
Net income 2024 * | -22M | Net income 2025 * | -25M | EV / Sales 2024 * | 116 x |
Net cash position 2024 * | 63.14M | Net cash position 2025 * | 40.52M | EV / Sales 2025 * | 190 x |
P/E ratio 2024 * |
-54.9
x | P/E ratio 2025 * |
-51.1
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 18.71% |
Latest transcript on Belite Bio, Inc
1 day | -1.06% | ||
1 week | -2.66% | ||
Current month | +3.57% | ||
1 month | +5.65% | ||
3 months | -11.57% | ||
6 months | +6.89% | ||
Current year | -8.09% |
Managers | Title | Age | Since |
---|---|---|---|
Yue Hsin Lin
CEO | Chief Executive Officer | 46 | 18-03-26 |
Hao Yuan Chuang
DFI | Director of Finance/CFO | 40 | 20-10-31 |
Nathan L. Mata
CTO | Chief Tech/Sci/R&D Officer | 58 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 22-03-31 | |
Yi Ta Lue
BRD | Director/Board Member | 47 | 22-03-31 |
John Longo
BRD | Director/Board Member | 55 | 22-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +3.95% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 42.05 | -1.06% | 50,164 |
24-05-09 | 42.5 | -0.70% | 22,084 |
24-05-08 | 42.8 | -0.93% | 31,388 |
24-05-07 | 43.2 | -0.23% | 24,030 |
24-05-06 | 43.3 | +0.23% | 35,629 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.09% | 1.23B | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- BLTE Stock